Adaptive Biotechnologies to Report Second Quarter Financial Results on August 10, 2020
July 09 2020 - 8:05AM
Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a
commercial stage biotechnology company that aims to translate the
genetics of the adaptive immune system into clinical products to
diagnose and treat disease, today announced it will report
financial results for the second quarter ended June 30, 2020 after
market close on Monday, August 10, 2020. Company management will
webcast a corresponding conference call beginning at 1:30 p.m.
Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on
the “Investors” section of the company website at:
www.adaptivebiotech.com. The webcast will be archived and available
for replay within 24 hours after the event.
About Adaptive
Biotechnologies
Adaptive Biotechnologies is a
commercial-stage biotech company focused on harnessing the inherent
biology of the adaptive immune system to transform the diagnosis
and treatment of disease. We believe the adaptive immune system is
nature’s most finely tuned diagnostic and therapeutic for most
diseases, but the inability to decode it has prevented the medical
community from fully leveraging its capabilities. Our proprietary
immune medicine platform reveals and translates the massive
genetics of the adaptive immune system with scale, precision and
speed to develop products in life sciences research, clinical
diagnostics, and drug discovery. We have two commercial products,
and a robust clinical pipeline to diagnose, monitor and enable the
treatment of diseases such as cancer, autoimmune conditions and
infectious diseases. Our goal is to develop and commercialize
immune-driven clinical products tailored to each individual
patient. For more information, please
visit adaptivebiotech.com and follow us on
www.twitter.com/adaptivebiotech.
Investor Contact:Karina
Calzadilla, Vice President, Investor RelationsCarrie Mendivil,
Gilmartin Groupinvestors@adaptivebiotech.com
Media Contact:Beth
Keshishianmedia@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Apr 2023 to Apr 2024